BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35488907)

  • 21. Regionalization of head and neck cancer surgery may fragment care and impact overall survival.
    Chen MM; Megwalu UC; Liew J; Sirjani D; Rosenthal EL; Divi V
    Laryngoscope; 2019 Jun; 129(6):1413-1419. PubMed ID: 30152007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
    Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Delayed Time to Treatment Initiation With Overall Survival and Recurrence Among Patients With Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population.
    Liao DZ; Schlecht NF; Rosenblatt G; Kinkhabwala CM; Leonard JA; Ference RS; Prystowsky MB; Ow TJ; Schiff BA; Smith RV; Mehta V
    JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1001-1009. PubMed ID: 31513264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
    Lee KC; Chuang SK; Philipone EM; Peters SM
    Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urban and rural differences in outcomes of head and neck cancer.
    Kim JD; Firouzbakht A; Ruan JY; Kornelsen E; Moghaddamjou A; Javaheri KR; Olson RA; Cheung WY
    Laryngoscope; 2018 Apr; 128(4):852-858. PubMed ID: 28940575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma.
    Abiri A; Yasaka TM; Lehrich BM; Goshtasbi K; Papagiannopoulos P; Tajudeen BA; St John MA; Harris JP; Kuan EC
    Laryngoscope; 2022 Mar; 132(3):584-592. PubMed ID: 34355791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Elsharawi R; Antonucci E; Sukari A; Cramer JD
    Head Neck; 2021 Jun; 43(6):1788-1796. PubMed ID: 33594736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis.
    Ramey SJ; Rich BJ; Kwon D; Mellon EA; Wolfson A; Portelance L; Yechieli R
    J Gastrointest Oncol; 2018 Dec; 9(6):1109-1126. PubMed ID: 30603130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of time-to-treatment initiation on survival in single primary non-small cell lung Cancer: A population-based study.
    Teng J; Liu Y; Xia J; Luo Y; Zou H; Wang H
    Heliyon; 2023 Sep; 9(9):e19750. PubMed ID: 37810045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation.
    Yusuf MB; Amsbaugh MJ; Burton E; Nelson M; Williams B; Koutourousiou M; Nauta H; Woo S
    J Neurooncol; 2018 Feb; 136(3):545-553. PubMed ID: 29143275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients.
    Chen MM; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma.
    Grønhøj C; Jensen D; Dehlendorff C; Nørregaard C; Andersen E; Specht L; Charabi B; von Buchwald C
    Clin Oncol (R Coll Radiol); 2018 Jun; 30(6):375-381. PubMed ID: 29526405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of delays in radiotherapy of head and neck cancer on outcome.
    Žumer B; Pohar Perme M; Jereb S; Strojan P
    Radiat Oncol; 2020 Aug; 15(1):202. PubMed ID: 32819389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.
    Patil VM; Noronha V; Joshi A; Nayak L; Pande N; Chandrashekharan A; Dhumal S; Bhattacharjee A; Banavali S; Prabhash K
    Indian J Cancer; 2017; 54(1):25-29. PubMed ID: 29199656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors.
    Nguyen MT; Wei W; Cooper G; Khorana AA; Kamath S
    Oncology (Williston Park); 2023 Jan; 37(1):19-24. PubMed ID: 36724138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.